These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 10534538)

  • 1. Proceedings of the 10th Asian Pacific Congress of Clinical Biochemistry in conjunction with the Australasian Association of Clinical Biochemists' 42nd Annual Scientific Conference.
    Clin Biochem Rev; 2004; 25(Supplement):S18-S128. PubMed ID: 18392121
    [No Abstract]   [Full Text] [Related]  

  • 2. Transient proteinuria after infusion of a gelatin plasma volume expander.
    Ambühl PA; Müller V; Binswanger U
    Clin Nephrol; 1999 Dec; 52(6):399-400. PubMed ID: 10604652
    [No Abstract]   [Full Text] [Related]  

  • 3. Pseudo-proteinuria following gelofusine infusion.
    Jones CM; Sumeray M; Heys A; Woolfson RG
    Nephrol Dial Transplant; 1999 Apr; 14(4):944-5. PubMed ID: 10328475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient massive proteinuria after gelatin-derived plasma expander (Gelofusine®) administration.
    Raghunath V; Marshall G; Ratanjee SK; Francis RS
    Nephrology (Carlton); 2013 Mar; 18(3):240-1. PubMed ID: 23432751
    [No Abstract]   [Full Text] [Related]  

  • 5. The gelatin-derived plasma substitute Gelofusine causes low-molecular-weight proteinuria by decreasing tubular protein reabsorption.
    ten Dam MA; Branten AJ; Klasen IS; Wetzels JF
    J Crit Care; 2001 Sep; 16(3):115-20. PubMed ID: 11689768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute renal failure after infusion of gelatin.
    BMJ; 1989 Dec; 299(6712):1399-400. PubMed ID: 2513978
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudoproteinuria following gelatin infusion.
    Hordijk W; Klasen IS; de Keijzer MH; Branten AJ; Wetzels JF
    Nephrol Dial Transplant; 1999 Nov; 14(11):2782-3. PubMed ID: 10534538
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of HES, dextran and gelatin on kidney function].
    Vogt N; Brinkmann A; Georgieff M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):268-70. PubMed ID: 9617430
    [No Abstract]   [Full Text] [Related]  

  • 9. [HES, dextran and gelatin--indications and tolerance].
    Laubenthal H; Sirtl C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):251-5. PubMed ID: 9617425
    [No Abstract]   [Full Text] [Related]  

  • 10. [Volume replacement and coagulation impairment].
    Levi M; De Jonge E
    Minerva Anestesiol; 2005 Dec; 71(12 Suppl 1):11-6. PubMed ID: 16434957
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravascular volume therapy with colloids in cardiac surgery.
    Lange M; Ertmer C; Van Aken H; Westphal M
    J Cardiothorac Vasc Anesth; 2011 Oct; 25(5):847-55. PubMed ID: 20709570
    [No Abstract]   [Full Text] [Related]  

  • 12. How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin.
    Moeller C; Fleischmann C; Thomas-Rueddel D; Vlasakov V; Rochwerg B; Theurer P; Gattinoni L; Reinhart K; Hartog CS
    J Crit Care; 2016 Oct; 35():75-83. PubMed ID: 27481739
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.